Tong Ren Tang Healthcare Investment — Healthcare M&A

Tong Ren Tang Healthcare Investment has postponed its Hong Kong IPO, a healthcare services other business in Hong Kong, for US$115 million. The company provides healthcare services based on traditional Chinese medicine and operates in the hospital-network services segment. Tong Ren Tang Healthcare Investment acquisition interest reflects demand for TCM-led healthcare services other acquisition exposure among investors in Hong Kong. The other acquisition deal type is an IPO delay rather than a completed healthcare M&A, with the offering of 108.15 million shares priced in a HK$7.30 to HK$8.30 range. After tepid subscription demand, the firm plans to refund application funds in full and cited prevailing market conditions amid a broader Hong Kong IPO boom.